by Usha Govindarajulu | Oct 29, 2021 | Biostatistics, Blog, Usha Govindarajulu
Mix and match boosters October 27, 2021 In recent news, the CDC/FDA are approving booster shots not only for Pfizerã but also for Modernaã and Johnson & Johnsonã, and even mixing and matching these boosters, but is there any science behind this...
by Usha Govindarajulu | Oct 14, 2021 | Biostatistics, Blog, Healtcare, Usha Govindarajulu
Antivirals EUA October 13, 2021 In recent news, Merck and Ridgeback has been hailing an oral anti-viral drug against Sars-CoV-2 that can cut the hospitalization and death rates in half according to their news posted on Oct 1, 2021 on their website. Apparently, the...
by Usha Govindarajulu | Sep 30, 2021 | Biostatistics, Blog, Healtcare, New York, Professor, Usha Govindarajulu
Booster shots for all vaccines September 30, 2021 The Centers for Disease Control and Prevention (CDC) has been promoting booster shots most recently for all vaccines for COVID-19: Pfizer, Moderna, and Johnson & Johnson. However, the Food & Druge...
by Usha Govindarajulu | Sep 15, 2021 | Biostatistics, Blog, Healtcare, Usha Govindarajulu
J&J Booster shots A more recent controversy has come up with the Johnson & Johnson (J&J) vaccine perhaps needing a booster shot sooner than the mRNA based vaccines for COVID-19. A current problem is there is no verifiable data or rather limited...
by Usha Govindarajulu | Sep 1, 2021 | Biostatistics, Blog, Epidemiology, Healtcare, Usha Govindarajulu
Waning of efficacy and interpretation A lot of controversy has come up with the boosters for the COVID-19 vaccines and efficacy. The Israeli study on efficacy comparing people vaccinated last year to people vaccinated this year seemed to indicate the efficacy...
